<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent findings have suggested a possible contribution of <z:e sem="disease" ids="C0008149" disease_type="Disease or Syndrome" abbrv="">chlamydial infection</z:e> to the pathogenesis of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in the general population </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role that chlamydial antibody status plays in <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> generation in haemodialysis (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) patients remains uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We measured carotid artery intima medial thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) over 4 years in 100 HD subjects (age: 58+/-10 years; time on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>: 13+/-7 years; male/female: 67/33) and examined potential associations between Chlamydia pneumoniae (Cp) antibody seropositivity and changes in carotid artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: During 4 years, carotid artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> increased significantly from 0.62+/-0.13 to 0.73+/-0.12 mm (P&lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression was significantly and positively correlated with age (r = 0.37, P&lt;0.01), log-transformed C-reactive protein (CRP; r = 0.33, P&lt;0.01) and log-transformed interleukin-6 (IL-6; r = 0.22, P&lt;0.04), but inversely correlated with blood <z:chebi fb="0" ids="16737">creatinine</z:chebi> (r = -0.36, P&lt;0.01) and albumin (r = -0.24, P&lt;0.02) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> increases were more prominent in patients positive for IgA antibodies (0.039+/- 0.022 mm/year, n = 52) compared with those without IgA antibodies (0.025+/-0.032 mm/year, n = 48) (P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>IgA seropositivity did not accelerate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression in patients with increased CRP (&gt;0.11 mg/dl, n = 53), but significantly increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> to a greater extent in IgA-positive subjects than in IgA-negative subjects having lower CRP (&lt;/=0.11 mg/dl, n = 47) (0.017+/-0.024 vs 0.034+/- 0.021 mm/year; P = 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate regression analysis revealed that serum <z:chebi fb="0" ids="16737">creatinine</z:chebi>, log-transformed CRP and IgA Cp seropositivity were independent risk factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression (P&lt;0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, IgG Cp antibody did not affect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression or carotid plaque formation </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression is associated with <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0004395'>malnutrition</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, persistent <z:e sem="disease" ids="C0008149" disease_type="Disease or Syndrome" abbrv="">chlamydial infection</z:e> may be associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> progression, but only in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> patients having low blood CRP </plain></SENT>
</text></document>